- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in astrazeneca
AstraZeneca Striving To Bring Innovative Medicines To Fuel Growth In India: Sanjeev Panchal
In an exclusive interaction with BW Businessworld, Sanjeev Panchal, Country President and MD AstraZeneca India speaks on the growing pharma industry, plans for investment in India, expectations from the new drugs bill and new launches for the company
Read More
AstraZeneca Grapples With Dual Lawsuits In London Over Covid-19 Vaccines
In the first of potentially dozens of lawsuits filed in England, AstraZeneca is facing two claims in London, including one from the husband of a woman who passed away after getting the COVID-19 vaccination from the Anglo-Swedish pharmaceutical company. Early in 2021, Britain became the first nation to offer the AstraZeneca COVID-19 vaccination at no cost; but, due to a tiny risk of blood clots, it later prohibited use of the vaccine in anyone younger than 40
Read More
AstraZeneca Beat Expectations For Q1 Profit & Revenue
Analysts on average were expecting USD 1.71 per share on sales of about USD 10.6 billion, according to company-compiled consensus estimates. AstraZeneca's performance in emerging markets was particularly strong, CEO Pascal Soriot said in a statement.
Read More
Evusheld May Not Protect Against Omicron Subvariant XBB.1.5: USFDA
The agency said it was closely monitoring the emergence of the XBB.1.5 subvariant, which accounted for 27.6 per cent of COVID-19 cases in the United States for the week ending Jan. 7
Read More
AstraZeneca Gets EU Nod For Heart Drug
If broader EU approval comes through, it will increase Forxiga's addressable heart failure patient population by 50 per cent, Ruud Dobber, who leads AstraZeneca's biopharma business said
Read More
Patient Selection For AstraZeneca, Daiichi Breast Cancer Drug Uncertain Say Experts
Early this year, researchers found that Enhertu could also benefit certain breast cancer patients whose HER2 levels were previously thought to be too low for the drug to have a meaningful effect
Read More
AstraZeneca To Take Over Neogene For Around $320 Mn In Oncology Expansion
The Anglo-Swedish drugmaker will make an initial payment of $200 million to Neogene, with an up to $120 million in milestone payments
Read More
Uk's C4X Discovery And Astrazeneca Signs $400 Mln Licensing Deal
C4XD said on Monday it would receive pre-clinical milestone payments worth up to USD 16 million ahead of the first clinical trial, including USD 2 million upfront
Read MoreAstraZeneca Beats Estimates In Quarterly Results With Cancer Drug Sales
The London-listed drugmaker’s core earnings came in at USD 1.67 cents per share
Read More
Astrazeneca Drug For Chronic Allergic Fails Late-Stage Trials
Despite the setback from the trial, AstraZeneca said it would continue to analyse the complete data set, which included 210 patients, and present its results at a future medical meeting.
Read More
AstraZeneca's Farxiga Reduces Fatality Rate In Cardiac Failure Patients Says Study
Farxiga is the first heart failure medication to show mortality benefit across all forms of heart failure, the company said. Detailed data from a study called 'DELIVER' evaluating Farxiga in patients with a form of heart failure characterised by mildly reduced or preserved ejection fraction was presented at the European Society of Cardiology congress in Barcelona
Read More
AstraZeneca Says EU Regulator Clears Covid Shot As Booster
The vaccine can now be used as a booster following the two-dose Vaxzevria schedule or by those who have been previously vaccinated by an mRNA vaccine, such as the ones made by Pfizer and BioNTech or Moderna
Read More
Astrazeneca Appoints Ram Mudaliar As India Lead Of CDI Division
The announcement follows the launch of the CDI India Division in October 2021.
Read More
AstraZeneca, Given As Booster, Gives Higher Antibodies Against Omicron
The increased response was seen in people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, the drugmaker said, adding that it would submit this data to regulators worldwide given the urgent need for boosters.
Read More
UK Marks Oxford/Astrazeneca Covid-19 Vaccine's One-Year Anniversary
British Prime Minister Boris Johnson credited the vaccine produced by scientists at the University of Oxford and manufactured by AstraZeneca with helping the world combat the COVID-19 pandemic and saving millions of lives.
Read More